Loading insider details...
Latest Form 4 (Mar 27, 2026): Sale of 1,500,000 VERO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 27, 2026 | Venus Concept Inc. (VERO) | Sale | 1,500,000 | n/a |
| Oct 20, 2023 | Venus Concept Inc. (VERO) | Purchase | 502,513 | $2.00M |
| Sep 12, 2023 | Venus Concept Inc. (VERO) | Purchase | 292,398 | $1.00M |
| Sep 6, 2023 | EyePoint Pharmaceuticals, Inc. (EYPT) | Sale | 20,000 | $198.0K |
| Sep 1, 2023 | EyePoint Pharmaceuticals, Inc. (EYPT) | Sale | 60,649 | $662.4K |
| Aug 30, 2023 | EyePoint Pharmaceuticals, Inc. (EYPT) | Sale | 60,858 | $712.7K |
| Aug 28, 2023 | EyePoint Pharmaceuticals, Inc. (EYPT) | Sale | 139,280 | $2.04M |
| Aug 24, 2023 | EyePoint Pharmaceuticals, Inc. (EYPT) | Sale | 46,778 | $683.8K |
| Jul 13, 2023 | Venus Concept Inc. (VERO) | Purchase | 500,000 | n/a |
| May 17, 2023 | Venus Concept Inc. (VERO) | Purchase | 280,899 | $2.00M |